[ascct] Fwd: [asio.annc] - ASIO Webinar: Omics Applications in Drug Discovery and Development
- From: Kristie Sullivan <KSullivan@xxxxxxxx>
- To: "ascct@xxxxxxxxxxxxx" <ascct@xxxxxxxxxxxxx>
- Date: Wed, 13 Nov 2013 04:30:59 -0500
Some of you might be interested in this webinar:
========================================================================================================================================
ASSOCIATION OF SCIENTISTS OF INDIAN ORIGIN - SOCIETY OF TOXICOLOGY
Tox-Webinar
In recognition of dynamic technological advances in various arenas of
toxicology testing in the 21st century, ASIO-SOT is hosting a series of
Tox-webinars. The goal is to educate students, post-docs and fellow
toxicologists with novel, cutting edge research technologies, and to foster
interaction and collaboration between scientists within the community. This
webinar is open to all, so please feel free to share the information with any
interested scientists.
Hereby, we proudly announce the first of this webinar series.
________________________________
Webinar Topic: “Omics” Applications in Drug Discovery and Development
Speaker: Dr. Shashi K Ramaiah, DVM, PhD, DACVP, DABT
Translational Biomarker Head, Drug Safety Research and Development,
Pfizer-Biotherapeutics, Cambridge, MA
Date: Friday, Dec 13th
Time: 12:00 - 1:00 p.m. Eastern Standard Time, USA
(EST)
[International attendees please convert your local time accordingly]
Registration: First come-first serve:
(https://aim-hq.webex.com/aim-hq/onstage/g.php?d=735586753&t=a)
-----------------------------------------------------------------------------------------------------------------------------
The webinar will address the application of “omics” approaches as biomarker
tools in drug discovery and development. Understanding transcription (mRNA,
miRNA), translation (and its modifications) and the metabolites are fundamental
to interrogate the mechanistic pharmacology and toxicity of complex human
disease. The insights lend itself to the development of biomarker signatures to
understand the mechanism of action of a drug and its efficacy, patient
enrichment and stratification in clinical trials. Hence, biomarker platforms
and technologies have evolved to provide practical applications as well as less
resource-intensive approaches.
Dr. Shashi Ramaiah (http://toxchange.toxicology.org/p/us/sn/uid=3856) is an
expert in the field of biomarker technologies and is currently serving as the
head of Translational Biomarkers at Pfizer Biotherapeutics in Cambridge, MA. He
is a board certified clinical Pathologist (DACVP) and toxicologist (DABT). He
has published more than 50 peer-reviewed journal articles, manuscripts and book
chapters. Dr. Ramaiah is currently responsible for scientific leadership,
supervision of laboratory operations and development of translational
pharmacology and safety biomarker strategies to support projects across
different therapeutic areas and modalities in Pfizer-Biotherapeutics portfolio.
Kristie Sullivan
Secretary, ASCCT
ksullivan@xxxxxxxxxxx<mailto:ksullivan@xxxxxxxxxxx>
Other related posts:
- » [ascct] Fwd: [asio.annc] - ASIO Webinar: Omics Applications in Drug Discovery and Development - Kristie Sullivan
